Occurrence of Skeletal-Related Events in Multiple Myeloma and Prostate Cancer Patients Receiving Standard Versus Extended-Interval Zoledronic Acid September 12, 2018Multiple MyelomaProstate Cancer
Fracture risk linked to mortality in women with myelomaAugust 29, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Treatment simulation could help personalize myeloma therapyJuly 31, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Promising phase 3 results for ixazomib in multiple myelomaJuly 13, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Ruxolitinib overcame lenalidomide resistance in myelomaJune 3, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
CAR T therapy to enter early testing in multiple myelomaMay 30, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
World Trade Center responders face greater cancer burden, including greater risk of multiple myelomaApril 26, 2018Leukemia, Myelodysplasia, TransplantationMultiple MyelomaGenitourinary CancerMelanomaOncology
More evidence links increased BMI to higher multiple myeloma riskMarch 17, 2018Multiple MyelomaLeukemia, Myelodysplasia, Transplantation
In myeloma, third ASCT is a viable optionMarch 14, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Treatment and Management of Multiple Myeloma (FULL)February 17, 2018OncologyMultiple MyelomaHematology
Meningococcal Arthritis Masking as Possible MyelomaFebruary 8, 2018Lymphoma & Plasma Cell DisordersMultiple Myeloma
Continue to opt for HDT/ASCT for multiple myelomaJanuary 5, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
Late-breaking abstracts highlight treatment advances in CLL, myeloma, and moreNovember 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Cyclophosphamide after transplant reduced GVHD in myeloma patientsNovember 20, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
New antibodies, drugs for refractory and relapsed myeloma are effective in patients over 65September 20, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
